Kevin Holmes

Title: Kevin Holmes: Innovator in Parathyroid Hormone Variants

Introduction

Kevin Holmes is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of parathyroid hormone variants. With a total of six patents to his name, Holmes has focused on innovations that improve patient care and treatment options.

Latest Patents

Holmes' latest patents revolve around parathyroid hormone (PTH) variants and their pharmaceutical compositions. These inventions aim to enhance the serum half-life and peak-trough ratios of PTH compositions. Furthermore, they provide methods for controlling serum calcium levels using these variants. His work also includes methods for treating hypoparathyroidism and hypocalcemia resulting from this condition, showcasing his commitment to addressing critical health issues.

Career Highlights

Throughout his career, Kevin Holmes has worked with prominent companies in the pharmaceutical industry, including Shire Human Genetic Therapies, Inc. and Shire-NPS Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Holmes has collaborated with several professionals in his field, including Angela Norton and Michael F. Concino. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

Kevin Holmes stands out as an influential inventor in the realm of parathyroid hormone research. His dedication to improving treatment options for patients with hypoparathyroidism and related conditions is commendable. Through his innovative patents and collaborations, he continues to make a significant impact in the pharmaceutical industry.